Drug Profile
Avotermin
Alternative Names: Human recombinant TGF beta 3; Juvista; RN 1001Latest Information Update: 15 Jan 2019
Price :
$50
*
At a glance
- Originator Renovo
- Developer Renovo; Takeda
- Class Recombinant proteins; Transforming growth factors
- Mechanism of Action Transforming growth factor beta3 stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Scars; Vascular restenosis